T. Rowe Price Associates »

Compass Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $37k 23k 1.58
2023-09-30 $41k 21k 2.00
2023-06-30 $59k 19k 3.19

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Compass Therapeutics

OrbiMed Advisors
Henderson Group
Blackstone Group
BlackRock
Vanguard Group
Vivo Capital
Blue Owl Capital Holdings
Avidity Partners Management
Baker Bros. Advisors
Monashee Investment Management
Millennium Management
Braidwell
Bank of New York Mellon
Connor, Clark & Lunn Investment Management
Charles Schwab Investment Management

View all funds holding Compass Therapeutics